rottlerin (NCI)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namerottlerin (NCI)
Drug Alias Namerottlerin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C delta inhibitors
TargetsProtein kinase C delta
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A